HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massimino D'Armiento Selected Research

Thyroid Diseases (Thyroid Disease)

1/2010TSH receptor and thyroid-specific gene expression in human skin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Massimino D'Armiento Research Topics

Disease

11Neoplasms (Cancer)
05/2016 - 02/2007
7Thyroid Neoplasms (Thyroid Cancer)
05/2016 - 07/2006
4Pain (Aches)
02/2007 - 01/2003
3Papillary Thyroid Cancer
01/2015 - 02/2011
3Anaplastic Thyroid Carcinoma
10/2014 - 06/2008
3Prostatic Neoplasms (Prostate Cancer)
02/2007 - 01/2003
2Genomic Instability
05/2016 - 02/2010
1Melanoma (Melanoma, Malignant)
01/2015
1Ovarian Neoplasms (Ovarian Cancer)
01/2015
1Hematologic Neoplasms (Hematological Malignancy)
01/2015
1Necrosis
10/2014
1Breast Neoplasms (Breast Cancer)
01/2014
1Aneuploidy (Aneuploid)
01/2014
1Chromosomal Instability (Chromosome Stability)
01/2014
1Hypothyroidism
06/2013
1Seminoma
04/2010
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
02/2010
1Thyroid Diseases (Thyroid Disease)
01/2010
1Neoplasm Metastasis (Metastasis)
02/2009
1Carcinoma (Carcinomatosis)
12/2006
1Renal Cell Carcinoma (Grawitz Tumor)
12/2006
1Kidney Neoplasms (Kidney Cancer)
12/2006
1Papillary Carcinoma
07/2006
1Adenoma (Adenomas)
07/2006
1Postoperative Pain
04/2005
1Wounds and Injuries (Trauma)
04/2005

Drug/Important Bio-Agent (IBA)

8Aurora KinasesIBA
05/2016 - 07/2006
4Messenger RNA (mRNA)IBA
01/2015 - 07/2006
4Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2012 - 02/2009
4Plasminogen Activators (Plasminogen Activator)IBA
11/2012 - 02/2009
4Proteins (Proteins, Gene)FDA Link
09/2011 - 07/2006
3AutoantibodiesIBA
01/2015 - 01/2010
3Plasminogen Activator Inhibitor 1IBA
02/2011 - 02/2009
3PlasminogenIBA
02/2011 - 02/2009
3Analgesics (Analgesic Drugs)IBA
02/2007 - 01/2003
3Hormones (Hormone)IBA
02/2007 - 01/2003
2Biomarkers (Surrogate Marker)IBA
01/2015 - 01/2014
2Phosphotransferases (Kinase)IBA
01/2014 - 07/2006
2Urokinase Plasminogen Activator ReceptorsIBA
02/2011 - 04/2010
2Aurora Kinase AIBA
02/2010 - 09/2007
1MLN 8237IBA
10/2014
12- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA
10/2014
1Biological ProductsIBA
01/2014
1ThyroglobulinFDA Link
01/2014
1Thyroxine (Levothyroxine)FDA LinkGeneric
06/2013
1Plasminogen Activator Inhibitor 2IBA
04/2010
1Tissue ExtractsIBA
04/2010
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
02/2010
1AntigensIBA
01/2010
1Peptides (Polypeptides)IBA
02/2009
1FibrinolysinFDA Link
02/2009
1Enzyme Precursors (Zymogens)IBA
02/2009
1Serine Proteases (Serine Protease)IBA
02/2009
1Monoclonal AntibodiesIBA
02/2009
1tozasertibIBA
06/2008
1Prednisone (Sone)FDA LinkGeneric
02/2007
1Pharmaceutical PreparationsIBA
02/2007
1Docetaxel (Taxotere)FDA Link
02/2007
1GemcitabineFDA Link
02/2007
1Prostate-Specific Antigen (Semenogelase)IBA
02/2007
1Zoledronic Acid (Zometa)FDA Link
02/2007
1Testosterone (Sustanon)FDA Link
01/2003
1Mitoxantrone (Novantrone)FDA LinkGeneric
01/2003

Therapy/Procedure

4Therapeutics
01/2014 - 12/2006
3Thyroidectomy
05/2010 - 04/2005
3Drug Therapy (Chemotherapy)
12/2006 - 01/2003
2Minimally Invasive Surgical Procedures
05/2010 - 04/2005
1Length of Stay
04/2005